Free shipping on orders over $200·For laboratory research use only

GHK-Cu + KPV Blend Research Reference

Two-component blend: GHK-Cu 50 mg + KPV 20 mg · Metallopeptide and small-peptide analytical research

Classification

TYPE

Two-component research blend

Domain

Proprietary Research Blends

Format

Lyophilized blended reference material (70 mg)

Quick Specs

Molecular Weight

401.9 + 342.4 g/mol

Purity

≥98% per component

Storage

−20 °C, protected from light

Appearance

Blue lyophilized powder

Solubility

Soluble in water

01

Research Overview

GHK-Cu + KPV is a two-component research blend containing GHK-Cu (50 mg), the copper(II) complex of the tripeptide Gly-His-Lys, and KPV (20 mg), the Lys-Pro-Val tripeptide from the C-terminus of α-MSH, in a single 70 mg lyophilized material.

Both components are small (about 400 and 340 g/mol), but they behave very differently: GHK-Cu carries a coloured, redox-active copper centre, while KPV has no metal and no oxidation-prone residues. This makes the blend a useful sample for developing methods for small polar peptides and metallopeptides, and a simple copper-containing matrix for comparison with KLOW and GLOW. It is supplied as a reference material for in vitro and analytical research only.

02

Structural & Sequence Context

The two components are close in size but chemically distinct.

GHK-Cu (50 mg)
Gly-His-Lys bound to copper(II), C₁₄H₂₂CuN₆O₄, 401.9 g/mol. Copper is held by the N-terminal amine, the deprotonated Gly–His backbone nitrogen and the histidine imidazole, giving a blue colour with a weak visible absorbance band near 600 nm.

KPV (20 mg)
Lys-Pro-Val, C₁₆H₃₀N₄O₄, 342.4 g/mol. Small and polar, with no aromatic, sulfur-containing or other easily oxidised residues. Its Lys-Pro N-terminus can cyclise to a diketopiperazine and is a substrate for DPP-IV.

Molar amounts
Per 70 mg vial this corresponds to about 124 µmol GHK-Cu and 58 µmol KPV, a molar ratio of roughly 2.1 : 1.

Copper content
A pure 1:1 complex would contain about 7.9 mg copper per 50 mg GHK-Cu. Measured values are usually lower because the material also contains counter-ions and water.

03

Mechanistic Research Context

Research interest in the blend focuses on analytical and stability behaviour.

A simple copper matrix
Because KPV has no methionine, cysteine or aromatic residues, it is largely insensitive to copper-catalysed oxidation. The blend therefore acts as a copper-containing control matrix when studying oxidation in more complex blends such as KLOW and GLOW, where TB-500’s methionine is at risk.

Copper retention
Whether GHK-Cu keeps its copper after drying and reconstitution can be followed by the visible band and by copper-specific analysis.

Component research
Both peptides have been studied separately in cell models of inflammatory signalling; their individual backgrounds are described on their own reference pages. No claims are made for the combination.

04

Laboratory Applications

Small polar peptide HPLC
Separating two early-eluting tripeptides, one of them a metal complex, in one run.

Orthogonal detection
214 nm for both peptides, around 600 nm selectively for the copper complex, and ICP-MS or atomic absorption for copper.

Ratio verification
Quantifying each component against its own standard, with copper analysis as an independent check on the GHK-Cu amount.

Comparative stability
Forced-degradation studies alongside KLOW and GLOW to isolate the effect of copper on other components.

05

Stability & Handling

Storage
Store the sealed vial at −20 °C, desiccated and protected from light. Let it reach room temperature before opening.

Choosing pH
Below about pH 4–5 GHK-Cu begins to lose copper, and strongly basic conditions favour copper hydroxide formation. KPV forms a diketopiperazine faster at neutral to basic pH. A pH of about 6–7, kept cold, with prompt use is the practical compromise.

Buffers
Use non-coordinating buffers such as MES or HEPES where copper chemistry matters; phosphate can interact with copper. Avoid EDTA and other chelators, and reducing agents, which strip or reduce the copper.

Light
Copper–peptide complexes are photo-active; minimise light exposure.

Labware
Use low-binding polypropylene tubes and avoid metal tools in contact with solutions. Freeze single-use aliquots and limit freeze–thaw cycles.

06

Analytical & Purity Considerations

Each component is identified and quantified separately.

HPLC
Both components elute early on reversed-phase C18; start at very low organic content with a shallow initial gradient, or use HILIC. Detect at 214 nm, with 205–210 nm improving KPV sensitivity. Acidic TFA mobile phases can partly dissociate GHK-Cu, so free GHK may appear; a more hydrophobic ion-pairing agent such as HFBA can improve retention.

Mass spectrometry
KPV gives [M+H]⁺ at m/z 343.2. GHK-Cu gives a copper doublet at m/z 402.1 (⁶³Cu) and 404.1 (⁶⁵Cu) in about a 69:31 ratio, which confirms bound copper.

Visible absorbance
The copper band near 600 nm is weak but selective; its loss indicates copper release.

Copper analysis
ICP-MS or atomic absorption measures total copper independently of the peptide, giving an orthogonal check on the GHK-Cu content.

Impurity profile
Free GHK, cyclo(Lys-Pro) and valine from KPV, truncated sequences and counter-ion content. Acceptance limits for component amounts are set in the lot specification.

07

Technical Specifications

Analytical Data & Molecular Properties
Sequence
GHK-Cu: Gly-His-Lys·Cu(II) · KPV: Lys-Pro-Val
Molecular Formula
GHK-Cu C₁₄H₂₂CuN₆O₄ · KPV C₁₆H₃₀N₄O₄
CAS Number
GHK-Cu 89030-95-5 · KPV 67727-97-3
Molecular Weight
401.9 and 342.4 g/mol; 50 / 20 mg per 70 mg vial
Purity
≥98% (HPLC) per component
Storage
−20 °C, desiccated, protected from light
Appearance
Blue lyophilized powder
Solubility
Soluble in water
08

Cross-Referenced Materials

09

Frequently Asked Questions

Which peptides does the GHK-Cu + KPV blend contain?

Two: GHK-Cu (50 mg), the copper complex of Gly-His-Lys, and KPV (20 mg), the tripeptide Lys-Pro-Val, giving 70 mg per vial.

How does it differ from KLOW?

KLOW contains GHK-Cu and KPV plus BPC-157 and TB-500. This blend has only the two tripeptides, so it lacks TB-500’s oxidation-prone methionine and is a simpler copper-containing matrix.

Why is the loading 50 : 20 mg rather than equal?

It is a formulation choice. In molar terms it gives about 124 µmol GHK-Cu to 58 µmol KPV, roughly a 2.1 : 1 ratio, because the two molecules have similar weights.

How should it be stored and reconstituted?

Store at −20 °C, desiccated and protected from light. Reconstitute in water or a non-coordinating buffer such as MES or HEPES at about pH 6–7, avoid EDTA and reducing agents, keep the solution cold and use it promptly.

Which analytical methods are recommended?

Reversed-phase HPLC with a low starting organic content (or HILIC) at 205–214 nm, LC-MS for identity including the copper doublet at m/z 402.1/404.1, visible absorbance near 600 nm for the copper complex, and ICP-MS or atomic absorption for total copper.

Is KPV affected by copper-catalysed oxidation in this blend?

Very little. KPV has no methionine, cysteine or aromatic residues, the usual targets of metal-catalysed oxidation. Its main degradation route is diketopiperazine formation, which is unrelated to copper.

Is this blend intended for human or veterinary use?

No. It is supplied strictly as a reference material for laboratory and analytical research and is not for human or animal use.

10

How to Cite This Reference

GHK-Cu + KPV Blend Research Reference. (2026). Pure Peptides Labs Research Catalogue. Retrieved from https://purepeptideslabs.net/research-catalogue/proprietary-research-blends/ghk-cu-kpv-blend/

Available for Research

Materials listed on this platform are supported by independent testing and published documentation for laboratory research contexts.

0
0
Your Cart
Your cart is emptyReturn to Shop